VBL Therapeutics announced an organizational streamlining designed to reduce operating expenses and preserve capital. As a result, VBL will reduce its workforce by approximately 35%. As part of the cost cutting initiatives, Dr. Ron Cohen, Dr. Bennett Shapiro and Ms. Alison Finger resigned from the board of directors, effective August 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 USD | -23.60% |
|
-21.91% | -64.02% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.02% | 6.85M | |
+14.84% | 121B | |
+18.31% | 112B | |
+4.48% | 22.57B | |
-18.26% | 20.82B | |
-14.23% | 16.3B | |
-16.64% | 16.19B | |
-42.36% | 16.17B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- NTBL Stock
- News Notable Labs, Ltd.
- VBL Therapeutics Announces Executive Resignations